Prescribing statins in general practice: who decides?

Affiliations

¹ Professor in Public Health, Norwich Medical School, Population Health and Primary Care, University of East Anglia, Norwich.
² Norwich Medical School, Population Health and Primary Care, University of East Anglia, Norwich.

Editorial

Nick Steel et al. Br J Gen Pract. 2017 Jun.

. 2017 Jun;67(659):246-247.

doi: 10.3399/bjgp17X690953.

¹ Professor in Public Health, Norwich Medical School, Population Health and Primary Care, University of East Anglia, Norwich.
² Norwich Medical School, Population Health and Primary Care, University of East Anglia, Norwich.

No abstract available

References

1. No authors listed. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) Lancet. 1994;344(8934):1383–1389. - PubMed
1. Collins R, Reith C, Emberson J, et al. Interpretation of the evidence for the efficacy and safety of statin therapy. Lancet. 2016;388(10059):2532–2561. - PubMed
1. Gitsels LA, Kulinskaya E, Steel N. Survival benefits of statins for primary prevention: a cohort study. PLoS One. 2016;11(11):e0166847. - PMC - PubMed
1. Zoungas S. A Clinical Trial of STAtin Therapy for Reducing Events in the Elderly (STAREE) 2016. https://clinicaltrials.gov/ct2/show/NCT02099123 (accessed 28 Apr 2017)
1. Ray KK, Seshasai SR, Erqou S, et al. Statins and all-cause mortality in high-risk primary prevention: a meta-analysis of 11 randomized controlled trials involving 65,229 participants. Arch Intern Med. 2010;170(12):1024–1031. - PubMed